CS

Chirag Suresh Sankhe

Active Director Director DIN 10215441
DIN 10215441 First appointment Jun 2023 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 2023
Shareholding value β€’β€’β€’β€’ Premium profile

About Chirag Suresh Sankhe

Data last updated:

Chirag Suresh Sankhe is a Director at Evaluxe Pharmaceuticals Private Limited (since 2023). The company operates in Pharma.

DIN 10215441
Primary Designation Director
Industry Pharma
First Appointment 27 Jun 2023
Oldest Company Age 3 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director27 Jun 20232023Active

Board colleagues of Chirag Suresh Sankhe

Directorship timeline

Open interactive timeline →
Evaluxe Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Chirag Suresh Sankhe

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Chirag Suresh Sankhe

Chirag Suresh Sankhe currently holds 1 directorship: Evaluxe Pharmaceuticals Private Limited (Director, since 27 Jun 2023).

Chirag Suresh Sankhe was first appointed on 27 Jun 2023 as Director at Evaluxe Pharmaceuticals Private Limited.

The current boards of Chirag Suresh Sankhe's companies include Juhi Suresh Sankhe (Evaluxe Pharmaceuticals Private Limited), Nuja Suresh Sankhe (Evaluxe Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available